Почетна › Затајење срца › Misuri › Kansas City
Kliničke studije za Затајење срца u gradu Kansas City, MO
25 studija za Затајење срца traži učesnike na lokacijama u gradu Kansas City i okolini (u krugu od oko 30 milja). Otvorite studiju da biste videli ko može da učestvuje i kako kontaktirati tim studije.
Zvanični tekst studije (na engleskom)
Tražite učesnike za studiju? Istaknite je na vrhu ove stranice — $99 za 30 dana →
A Study to Test Whether Vicadrostat in Combination With Empagliflozin Helps People With Heart Failure
Тражи се учесникФаза 3
- Kansas City VA Medical Center, Kansas City
- North Kansas City Hospital, North Kansas City · 2 ми удаљено
A Study to Test Whether Vicadrostat (BI 690517) in Combination With Empagliflozin Helps People With Heart Failure and a Weak Pumping Function of the Left Side of the Heart
Тражи се учесникФаза 3
- Kansas City VA Medical Center, Kansas City
Barostim-Enabled NEurohormonal Intervention For Improving Treatment of Heart Failure
Тражи се учесник
- Saint Luke's Hospital of Kansas City, Kansas City
Trial to Evaluate Safety And Effectiveness of Mechanical Circulatory Support in Patients With Advancing Heart Failure
Тражи се учесник
- St. Luke's Hospital, Kansas City
Product Performance Report: Evaluate Long-term Reliability & Performance of Medtronic Marketed Cardiac Therapy Products
Тражи се учесникОпсервациона студија
- Kansas City, Kansas City
Study With Omecamtiv Mecarbil (CK-1827452) to Treat Chronic Heart Failure With Severely Reduced Ejection Fraction
Тражи се учесникФаза 3
- Saint Luke's Hospital of Kansas City, Kansas City
ELEVATE-HFpEF Clinical Study
Тражи се учесник
- Saint Lukes Mid America Heart Institute, Kansas City
Maridebart Cafraglutide in Heart Failure With Preserved or Mildly Reduced Ejection Fraction and Obesity
Тражи се учесникФаза 3
- Saint Luke's Hospital of Kansas City, Kansas City
A Study to Learn More About How Safe Finerenone is, When it is Taken for a Longer Time With Standard Treatment, in Children and Young Adults With Heart Failure and Left Ventricular Systolic Dysfunction
Тражи се учесникФаза 3
- Children's Mercy Hospital Kansas City - Cardiology, Kansas City
CCM OPEN HF Registry
Тражи се учесникОпсервациона студија
- Saint Luke's Hospital Mid America Heart Institute, Kansas City
- Saint Luke's Hospital of Kansas City, Kansas City
Assessment of CCM in HF With Higher Ejection Fraction
Тражи се учесник
- St. Lukes Hospital Kansas City (Mid America Heart Institute), Kansas City
Phase III Study Investigating Heart Failure and Cardiovascular Death With Baxdrostat in Combination With Dapagliflozin
Тражи се учесникФаза 3
- Research Site, Kansas City
- Research Site, Kansas City
The WiSE®-UP Study (The WiSE System Utilization & Performance Study)
Тражи се учесникОпсервациона студија
- St. Luke's Hospital of Kansas City, Kansas City
NORM-HF Pivotal Study
Тражи се учесник
- Saint Luke's Hospital of Kansas City, Kansas City
A Study to Learn More About How Well Finerenone Works, How Safe it is, and How it Moves Into, Through, and Out of the Body Compared to Placebo When Taken With Standard Treatment in Children With Heart Failure and Left Ventricular Systolic Dysfunction
Тражи се учесникФаза 3
- Children's Mercy Hospital Kansas City - Cardiology, Kansas City
A Study of EDG-15400 in Adults With Heart Failure With Preserved Ejection Fraction (EQUINOX-HFpEF)
Тражи се учесникФаза 2
- Local Institution - 11, Kansas City
Study to Evaluate the Effect of Balcinrenone/Dapagliflozin in Patients With Heart Failure and Impaired Kidney Function
Тражи се учесникФаза 3
- Research Site, Kansas City
- Research Site, Kansas City
A Study to Investigate CV Outcomes With Elecoglipron Compared With Placebo in Adult Participants With HFpEF or HFmrEF
Тражи се учесникФаза 3
- Research Site, Kansas City
A Study to Determine the Efficacy and Safety of Finerenone and SGLT2i in Combination in Hospitalized Patients With Heart Failure (CONFIRMATION-HF)
Тражи се учесникФаза 3
- CON-10002 Kansas City, MO Investigative Site, Kansas City
A Study to Determine the Efficacy and Safety of Finerenone on Morbidity and Mortality Among Hospitalized Heart Failure Patients
Тражи се учесникФаза 3
- Kansas City, MO Investigative Site 10002, Kansas City
A Prospective Registry Study to Assess Real-world Patient Characteristics, Treatment Patterns, and Longitudinal Outcomes in Patients Receiving Mavacamten and Other Treatments for Symptomatic Obstructive Hypertrophic Cardiomyopathy (Obstructive-HCM)
Тражи се учесникОпсервациона студија
- St. Luke's Mid-America Heart Institute, Kansas City
A Research Study to Look at How Well NNC0487-0111 Works Compared to Placebo in People With Heart Failure and Obesity
Тражи се учесникФаза 3
- Clinical Research Consultants, JCCT Co, Kansas City
A Study to Evaluate Finerenone on Clinical Efficacy and Safety in Patients With Heart Failure Who Are Intolerant or Not Eligible for Treatment With Steroidal Mineralocorticoid Receptor Antagonists
Тражи се учесникФаза 3
- FIN-10002 Kansas City, MO Investigational Site, Kansas City
PROACTIVE-HF-2 Trial Heart Failure NYHA Class II and III
Тражи се учесник
- St. Lukes/ Mid-American Heart Institute, Kansas City
HF2 Registry - Hemodynamic Frontiers in Heart Failure Registry
Тражи се учесникОпсервациона студија
- Saint Luke's Health System, Kansas City
Studije za Затајење срца u drugim gradovima
- New York City, NY51 студија
- Boston, MA46 студија
- Dallas, TX42 студија
- Houston, TX35 студија
- Cleveland, OH31 студија
- Philadelphia, PA31 студија
- San Francisco, CA29 студија
- Chicago, IL28 студија
- Durham, NC25 студија
- St. Louis, MO24 студија
- Indianapolis, IN24 студија
- Atlanta, GA23 студија
Ostale studije u gradu Kansas City
- Рак дојке34 студија
- Немалоклетни карцином плућа29 студија
- Рак (све врсте)21 студија
- Рак плућа18 студија
- Колоректални карцином16 студија
- Рак простате16 студија
- Метастатски карцином14 студија
- Akutna mijeloidna leukemija14 студија
- Рак јајника12 студија
- Dijabetes tipa 211 студија
- Кардиоваскуларне болести11 студија
- Гојазност10 студија
Sa sajta ClinicalTrials.gov, podaci preuzeti 15. 11. 2026.. Svaka studija ima svoje kriterijume za uključivanje; tim studije odlučuje ko može da učestvuje.